Lilly 'Disappointed' by Cancer Drug Study

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced what it calls disappointing results of a study of a new cancer drug. The pharmaceutical giant says the Phase 3 study of Lartruvo, which aims to treat patients with advanced or metastatic soft tissue sarcoma, did not meet its primary endpoints.

The study involved the use of Lartruvo in combination with doxorubicin, which alone is the standard of care treatment for STS. Lilly says the study showed no difference in survival for patients involved. 

Lilly says the combination of Lartruvo and doxorubicin previously showed a benefit in a 133-patient, U.S.-only, randomized Phase 2 trial, which led to an accelerated approval by the U.S. Food and Drug Administration. The company is now working with global regulators to determine the appropriate next steps for the drug.

"Lilly was surprised and disappointed that LARTRUVO did not improve survival for patients with advanced soft tissue sarcoma in this study," said Anne White, president of Lilly Oncology. "Lilly is committed to helping people who have soft tissue sarcoma and we will carefully study the detailed data in an effort to better understand the different results between the two trials."

Lilly says it is suspending promotion of Lartruvo for the time being. The company expects to incur a charge in the first quarter related to Lartruvo, which could range from $70 million to $90 million. 

  • Perspectives

    • Indiana's Regrettable Struggle to Pass Hate Crime Legislation

      It shouldn’t be this hard. The Senate’s Public Policy Committee voted 9-1 in favor of SB-12 this week, a bill that would have codified (as written) hate crime bias to include protections for race, religion, color, sex, gender identity, disability, national origin, ancestry, sexual orientation, and age. SB-12 then made its way to the full Senate. Preceded by a lengthy deliberation by the Senate’s Republican caucus, the Senate voted 33-16 in favor of a watered-down...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Picture Courtesy: Ratio Architects

      Hilton Bringing New Hotel Brand to Indy

      Hilton (NYSE: HLT) has chosen Indianapolis as one of three markets where it will roll out its new Signia Hilton brand. The hospitality company says Signia Hilton will target meeting professionals and business travelers hosting and attending large events. The 800-room Signia Hilton will be the larger of the two hotel towers planned for the Pan Am Plaza site as part of a $120 million Indiana Convention Center expansion. Visit Indy Senior Vice President Chris Gahl expects...

    • Rolls-Royce to Make Indy Jobs Announcement

      Rolls-Royce Corp. in Indianapolis will Monday make an announcement about a new campaign and jobs. Few details were provided, however the company says the announcement will involve a new U.S. defense engine program.

    • (image courtesy WTHR-TV)

      Governor Holcomb Launches Next Level Broadband Program

      Governor Eric Holcomb has launched a program dedicating $100 million to bring broadband to rural areas of the state. The Next Level Broadband Program will be overseen by Lt. Governor Suzanne Crouch and the Indiana Office of Community and Rural Affairs. The Indiana Department of Transportation will administer grants and provide technical support.  

    • Hoosier Hospitals Make Top 100 Lists

      Several Indiana hospitals are included in two lists from The Chartis Center for Rural Health that feature the top 100 critical access hospitals and rural and community hospitals. The healthcare advisory services and analytics company says the lists are based on the results of the Hospital Strength Index from iVantage Health Analytics, which provides a "comprehensive and objective assessment of rural provider performance." The Chartis Center says the hospitals that make...
    • Indiana's Regrettable Struggle to Pass Hate Crime Legislation

      It shouldn’t be this hard. The Senate’s Public Policy Committee voted 9-1 in favor of SB-12 this week, a bill that would have codified (as written) hate crime bias to include protections for race, religion, color, sex, gender identity, disability, national origin, ancestry, sexual orientation, and age. SB-12 then made its way to the full Senate. Preceded by a lengthy deliberation by the Senate’s Republican caucus, the Senate voted 33-16 in favor of a watered-down...